Bramacare has launched AMY, a clinician-developed, AI-enabled platform specifically designed to aid eating disorder and rehabilitation services.
AMY is an intuitive system designed to reduce fragmentation between care services. It will function as a single, unified system capable of integrating physical health monitoring, risk stratification, multidisciplinary care planning, and regulatory compliance.
Built around the Medical Emergencies in Eating Disorders (MEED) guidelines, AMY embeds national standards for physical health monitoring and escalation directly into clinical workflows.
This supports safer, faster, and more consistent decision-making, while making clinical governance structural rather than procedural. Alerts are time-stamped and tracked to resolution, and audit trails are generated automatically to create robust evidence base for every patient interaction.
The platform automates monitoring schedules, flags missing observations and overdue investigations, and generates safeguarding and compliance reports without manual compilation. Real-time dashboards provide managers and safeguarding leads with immediate visibility of service-level risk and performance.
AMY’s AI engine enables continuous, real-time risk stratification across multiple domains, including suicide and self-harm, falls, ligature risk, and medication-related concerns.
Risk profiles update automatically as new data is entered, with configurable escalation pathways routing information to senior clinicians, GPs, consultants, acute services, or safeguarding leads in line with local protocols.
The platform also includes dedicated modules for dietetic planning, medication management, psychological intervention, occupational therapy, and individualised risk assessments.
A single shared patient record and version-controlled care plans ensure all clinicians are working from the most up-to-date information, regardless of shift or discipline to eliminate fragmentation of data between services.
AMY incorporates role-based access controls, dual authorisation for high-risk decisions, encryption of patient data, and aligns with the NHS Data Security and Protection Toolkit and GDPR.
The launch comes at a time of rising demand and pressure on specialist services. At least 1.25 million people in the UK are living with an eating disorder, and the number of children and young people starting treatment has increased by almost 40% since the pandemic, reaching 11,174 in 2024/25.
Despite additional NHS investment of £54 million per year since 2023/24, access and waiting time standards remain unmet, with fewer than 80% of urgent referrals beginning treatment within the required one-week window.
Dr Ramoo, Clinical Lead and Co-Founder of Bramacare, said: “Specialist eating disorder care is one of the most clinically complex areas of medicine. AMY was developed to provide clinical teams with a more effective way to make faster, safer, and more consistent decisions, while reducing the admin burden they already carry. Every feature of the platform is designed from within the clinical reality, ensuring it truly supports the day-to-day work of clinicians and the safety of patients.”
Amy Dingle, Bramacare’s first patient and the platform’s namesake, said: “For anyone going through what I went through, it’s incredibly important that the people caring for you have the right information at the right time and are fully coordinated in their approach.
“AMY will give clinical teams the tools and insight they need to deliver the highest standard of care, providing patients with what I was fortunate to receive – a real chance at recovery.”
AMY was developed by a clinical design team with direct specialist eating disorder experience. It is currently in structured clinical evaluation ahead of UKCA Class IIb conformity assessment under UK MDR 2002.
First pilots for AMY will be happening in 2026 with NHS trust partners and is now available for procurement conversations with NHS trusts, independent specialist providers, and health system commissioners.
There’s plenty of other editorial on our sister site, Electronic Specifier! Or you can always join in the conversation by visiting our LinkedIn page.
